A Study of DTC in Patients With AIDS and AIDS Related Complex
- Conditions
- HIV Infections
- Registration Number
- NCT00002069
- Lead Sponsor
- Merieux Institute
- Brief Summary
To determine if ditiocarb sodium (sodium diethyldithiocarbamate; DTC) restores immune and host defense function; if DTC ameliorates the AIDS related complex (ARC) symptoms in patients with AIDS and ARC; if DTC prevents progression from ARC to AIDS or progression of AIDS; and if DTC prolongs survival in AIDS.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (8)
Univ of Arizona / Arizona Cancer Ctr
🇺🇸Tucson, Arizona, United States
USC School of Medicine / Norris Cancer Hosp
🇺🇸Los Angeles, California, United States
San Francisco AIDS Clinic / San Francisco Gen Hosp
🇺🇸San Francisco, California, United States
Portion Med Group
🇺🇸Sherman Oaks, California, United States
Florida Keys Memorial Hosp
🇺🇸Key West, Florida, United States
SUNY / Health Sciences Ctr at Brooklyn
🇺🇸Brooklyn, New York, United States
Duke Univ Med Ctr
🇺🇸Durham, North Carolina, United States
Dr Gary Brewton
🇺🇸Houston, Texas, United States
Univ of Arizona / Arizona Cancer Ctr🇺🇸Tucson, Arizona, United States